Beigene Ltd ADR (NQ: BGNE )
193.82
-1.81
(-0.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Beigene Ltd ADR
![](https://mms.businesswire.com/media/20210915005310/en/906368/4/Brukinsa.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/insider-buying_29.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1805.png)
![](https://mms.businesswire.com/media/20210912005031/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20210912005021/en/1199527/5/BGNE_Logo_0821.jpg)
BeiGene to Present Latest Findings in Robust Lung Cancer Portfolio at ESMO Congress 2021
September 12, 2021
From BeiGene, Ltd.
Via Business Wire
![](https://g.foolcdn.com/editorial/images/641813/fda-approved.jpg)
Why BeiGene Stock Is Soaring This Week
September 02, 2021
Via The Motley Fool
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1699.png)
![](https://mms.businesswire.com/media/20210901006049/en/902566/5/BeiGene_10_Years.jpg)
U.S. FDA Grants BRUKINSA® (Zanubrutinib) Approval in Waldenström’s Macroglobulinemia
September 01, 2021
From BeiGene, Ltd.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_91.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884775_1920_85.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/peek_into_the_marketnew_244.png)
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises Over 3%
August 23, 2021
Via Benzinga
Topics
Stocks
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_271.png)
![](https://mms.businesswire.com/media/20210822005013/en/836052/5/BeiGene_10_Years.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1507.png)
![](https://mms.businesswire.com/media/20210817005501/en/836052/5/BeiGene_10_Years.jpg)
![](https://mms.businesswire.com/media/20210816005187/en/836052/5/BeiGene_10_Years.jpg)
![](https://mms.businesswire.com/media/20210805006018/en/836052/5/BeiGene_10_Years.jpg)
BeiGene Reports Second Quarter 2021 Financial Results
August 05, 2021
From BeiGene, Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20210803005337/en/836052/5/BeiGene_10_Years.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_359.jpg)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1263.png)
![](https://mms.businesswire.com/media/20210729006225/en/836052/5/BeiGene_10_Years.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_254.png)
![](https://g.foolcdn.com/editorial/images/635650/test-tubes-with-green-arrow-pointing-up.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1186.png)
![](https://mms.businesswire.com/media/20210726005208/en/836052/5/BeiGene_10_Years.jpg)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_adeolu-eletu-e7rlgujjazc-unsplash.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_353.jpg)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.